Combination of the CCL5-Derived Peptide R4.0 With Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.03559-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search